Cargando…
Programmable m(6)A modification of cellular RNAs with a Cas13-directed methyltransferase
N(6)-methyladenosine (m(6)A) is the most widespread internal mRNA modification in humans. Despite recent progress in understanding the biological roles of m(6)A, the inability to install m(6)A site-specifically in individual transcripts has hampered efforts to elucidate causal relationships between...
Autores principales: | Wilson, Christopher, Chen, Peter J., Miao, Zhuang, Liu, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718427/ https://www.ncbi.nlm.nih.gov/pubmed/32601430 http://dx.doi.org/10.1038/s41587-020-0572-6 |
Ejemplares similares
-
m(6)A-mRNA Methylation Regulates Gene Expression and Programmable m(6)A Modification of Cellular RNAs With CRISPR-Cas13b in Renal Cell Carcinoma
por: Gan, Ying, et al.
Publicado: (2022) -
Targeting cellular mRNAs translation by CRISPR-Cas9
por: Liu, Yuchen, et al.
Publicado: (2016) -
Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications
por: Tang, Tian, et al.
Publicado: (2021) -
Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase
por: Xia, Zhen, et al.
Publicado: (2021) -
Programmable N6-methyladenosine modification of CDCP1 mRNA by RCas9-methyltransferase like 3 conjugates promotes bladder cancer development
por: Ying, Xiaoling, et al.
Publicado: (2020)